| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |